<DOC>
	<DOCNO>NCT00818597</DOCNO>
	<brief_summary>The purpose study investigate effect extracorporeal application bed-side bioreactor contain human donor granulocyte course outcome septic shock human .</brief_summary>
	<brief_title>Extracorporeal Immune Support System ( EISS ) Treatment Septic Patients</brief_title>
	<detailed_description />
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<criteria>sepsis least one organ failure ( severe sepsis ) septic shock Participation another study within last 30 day Earlier participation study Pregnancy Bleeding , clinically control ( need 2 red blood celltransfusions per day ) Hemodynamic shock 12 hour ( systolic BP &lt; 90mmHg ) despite adequate therapy HIV infection HCV infection , active</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>septic shock</keyword>
	<keyword>immunoparalysis</keyword>
	<keyword>extracorporeal</keyword>
	<keyword>granulocyte bioreactor</keyword>
	<keyword>plasmapheresis</keyword>
</DOC>